证券代码：301305 证券简称：朗坤科技 公告编号：2025-054 深圳市朗坤科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或者重大遗漏。 特别提示： 为 1.34%，本次注销完成后，公司总股本由 244,511,700 股变更为 241,228,204 股。 深圳市朗坤科技股份有限公司（以下简称"公司"）因实施注销回购专用 证券账户股份导致公司总股本、无限售条件流通股数量发生变化，根据《上市 公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号—回购股 份》等相关规定，现就回购股份注销完成暨股份变动情况公告如下： 一、本次回购股份的批准和实施情况 和第三届监事会第七次会议、2024 年第一次临时股东大会，审议通过了《关于 回购公司股份方案的议案》，同意公司使用自有资金和部分公司首次公开发行 人民币普通股（A 股）取得的超募资金，以集中竞价交易方式回购公司已发行 的部分人民币普通股（A 股），本次回购的股份将全部予以注销并相应减少公 司注册资本。本次回购的资金总额为不低于人民币 5,500 万元（含），不超过人 民币 11,000 万元（ ...

关于回购股份注销完成暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或者重大遗漏。 特别提示： 1、本次注销的回购股份数量为 3,283,496 股，占注销前公司总股本的比例 为 1.34%，本次注销完成后，公司总股本由 244,511,700 股变更为 241,228,204 股。 证券代码：301305 证券简称：朗坤科技 公告编号：2025-054 深圳市朗坤科技股份有限公司 公司于 2025 年 4 月 23 日、2025 年 5 月 16 日分别召开了第三届董事会第二 十二次会议、2024 年年度股东大会，审议通过了《关于减少注册资本暨修订< 公司章程>的议案》。公司于 2025 年 5 月 16 日刊登了《关于注销回购股份减少 注册资本暨通知债权人的公告》（公告编号：2025-043）。公司于 2025 年 6 月 16 日在中国证券登记结算有限责任公司深圳分公司办理完毕上述 3,283,496 股回 购股份的注销事宜。本次注销回购股份的数量、完成日期、注销期限符合回购 股份注销相关法律法规的要求。 三、本次回购股份注销后股权结构变动情况 | ...

Group 1 - Banqiao Qiancheng signed a significant contract with Mango Film and Television for a total amount of 372 million yuan, accounting for 50.65% of the company's audited main business income for 2024 [1] - The contract allows Mango Film and Television to use the new media and traditional media broadcasting rights for related film and television works globally, positively impacting Banqiao Qiancheng's financial status and operating performance in 2025 and beyond [1] - Jingwei Huikai plans to sell its wholly-owned subsidiary Changsha Yushun for 112 million yuan, which will no longer be included in the consolidated financial statements after the transaction [1] Group 2 - Minsheng Health's subsidiary received a patent for a strain of lactic acid bacteria that significantly improves sarcopenic obesity, although it has not yet been applied to the company's products [2] - Dafu Technology intends to transfer 27% of its subsidiary Shenzhen Peitian Intelligent Manufacturing Equipment Co., Ltd. for 192 million yuan, maintaining a controlling stake post-transaction [3] - Feilong Co. received orders for high-power electronic water pumps for data centers from a well-known global power electronics provider [4] Group 3 - Yatai Co. was selected as a supplier for a foreign brand's EPB project, with a total sales amount of approximately 680 million yuan over a five-year lifecycle [5] - Gansu Energy's 1 million kilowatt wind-solar integrated project has received approval, representing over 10% of the company's installed capacity by the end of 2024 [6] - Jilin Aodong's subsidiary received approval for a drug supplement application for "Tang Le Capsule," used to treat symptoms related to diabetes [7] Group 4 - Shanshui Technology plans to invest 6 billion yuan in a new chemical materials project, expected to generate an annual output value of 8 billion yuan upon completion [8] - Dazhu CNC's H-share issuance application has been accepted by the China Securities Regulatory Commission [9] - Zhujiang Beer announced the resignation of its chairman due to retirement age, with a new chairman elected on the same day [10] Group 5 - Longkun Technology won a bid for a waste collection service project worth 21.57 million yuan, with a service period of one year [11] - Zhongnan Culture plans to provide financial support of up to 20 million yuan to its subsidiary for daily operational needs [12] - Shangfeng Cement's investment in a company applying for an IPO on the Sci-Tech Innovation Board has been accepted [13] Group 6 - Chuanheng Co. received a patent for a system and method for harmless treatment of phosphorus tailings [14] - Toukeng Life's seven medical device registration applications have been accepted, covering various diagnostic fields [15] - Xingqi Eye Medicine's clinical trial for a new eye gel has commenced with the first subject enrolled [16] Group 7 - Jiebang Technology plans to provide financial support of up to 60 million yuan to its subsidiary for operational needs [17] - Shenzhen Airport reported a passenger throughput of 5.54 million in May, a year-on-year increase of 15.67% [18] - Wan'an Technology received a cash dividend of 30 million yuan from its wholly-owned subsidiary [19] Group 8 - Jiuchuan Bio received a medical device registration certificate for a cystatin C assay kit [20] - Hongqiang Co. obtained a safety production license for its subsidiary, marking the official production of a new project [21] - Xiangtan Electric plans to issue convertible bonds totaling 487 million yuan [22] Group 9 - Guangwei Composite signed a supplementary material procurement contract worth 658 million yuan [23] - Jichuan Pharmaceutical announced a comprehensive tender offer starting June 18, with a price of 26.93 yuan per share [24] - Aerospace Rainbow plans to distribute cash dividends of 0.60 yuan per share [25] Group 10 - Industrial Bank plans to distribute cash dividends of 1.06 yuan per share, totaling 22.433 billion yuan [26] - China Automotive Research will repurchase and cancel 230,800 restricted shares due to the retirement of original incentive objects [27] - Annie Co. announced abnormal stock trading fluctuations but confirmed no significant changes in its operations [28] Group 11 - Giant Network confirmed no undisclosed significant matters following abnormal stock trading fluctuations [29]

证券代码：301305 证券简称：朗坤科技 公告编号：2025-053 深圳市朗坤科技股份有限公司 关于为子公司提供担保事项的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市朗坤科技股份有限公司（以下简称"公司"）分别于 2025 年 4 月 23 日、2025 年 5 月 16 日召开第三届董事会第二十二次会议、第三届监事会第十三 次会议以及 2024 年年度股东大会，审议通过了《关于公司 2025 年度对外担保额 度预计的议案》。为满足公司及合并报表范围内子公司业务发展融资需求（包括 但不限于办理人民币流动资金贷款、项目贷款、贸易融资、银行承兑汇票、保函、 信用证等形式），同意公司及子公司在保证规范运营和风险可控的前提下，2025 年度新增不超过人民币 159,244.50 万元的担保额度。其中，为资产负债率高于 70%的子公司提供担保额度合计人民币 2,638.70 万元，为资产负债率低于 70%的 子公司提供担保额度合计不超过人民币 156,605.80 万元。公司可以根据实际情况， 在上述担保额度范围内，以不超过资产负债率 70%为标 ...

证券代码：301305 证券简称：朗坤科技 公告编号：2025-052 深圳市朗坤科技股份有限公司 关于收到中标通知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 2025 年 6 月 12 日 ， 中 国 深 圳 政 府 采 购 网 （ http://zfcg.szggzy.com:8081/gsgg/002001/002001004/002001004001/20250612/26 91c1ec-f5cf-46cf-91f5-b2fe6fe8e78a.html）发布了《罗湖区餐厨、果蔬垃圾收运服 务项目中标（成交）结果公告》，深圳市朗坤科技股份有限公司（以下简称"公 司"）为上述项目中标候选人，中标金额为 21,567,120.00 元，具体内容详见公 司 2025 年 6 月 13 日在巨潮资讯网（www.cninfo.com.cn）上披露的《关于中标 候选人公示的提示性公告》（公告编号：2025-051）。2025 年 6 月 16 日，公司 收到了招标代理机构深圳市加乐咨询有限公司发来的《中标（成交）通知书》。 一、中标通知书主要内容 1 ...

Summary of Key Points Core Viewpoint - Langkun Technology (301305) has shown a slight increase in stock price, closing at 17.61 yuan, reflecting a 0.4% rise from the previous week, with significant trading activity noted [1]. Trading Information - On June 9, Langkun Technology recorded a large transaction amounting to 3.1981 million yuan [1][3]. Company Announcements - Langkun Technology announced a guarantee for its subsidiary, which has an asset-liability ratio exceeding 70%, providing a performance guarantee of 800,000 yuan [1][3]. - The company approved a new guarantee limit of up to 1.592445 billion yuan for the year 2025 [1]. - The subsidiary, Raoping Langkun Agricultural Resources Technology Co., Ltd., established in May 2018, has total assets of 34.4756 million yuan and total liabilities of 24.7820 million yuan as of March 31, 2025 [1]. - The total guarantee amount for the company and its subsidiaries is 4.14194 billion yuan, with a cumulative guarantee balance of 1.8379524 billion yuan, representing 51.52% of the latest audited net assets [1].

Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]

证券代码：301305 证券简称：朗坤科技 公告编号：2025-051 深圳市朗坤科技股份有限公司 关于中标候选人公示的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 特别提示： 1、下述项目目前尚处于中标候选人公示期，公司能否取得《中标通知书》 并最终签署正式合同，存在一定的不确定性。 2、下述项目最终中标金额以正式签署的合同为准，可能存在最后金额总量 不及预估的情形，公司将根据实际进展情况及时履行信息披露义务，敬请广大投 资者注意投资风险。 2、项目服务内容：本项目收运对象为餐厨垃圾（含废弃食用油脂）和果蔬 垃圾。 3、中标金额：21,567,120.00 元 二、中标候选人公示内容 本次中标候选人公示媒体是中国深圳政府采购网，招标人为深圳市罗湖区城 市管理和综合执法局，招标代理机构为深圳市加乐咨询有限公司。公示期为 2025 年 6 月 12 日至 2025 年 6 月 15 日。具体内容详见中国深圳政府采购网 （ http://zfcg.szggzy.com:8081/gsgg/002001/002001004/002001004001/ ...

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 深圳市朗坤科技股份有限公司（以下简称"公司"）股东深圳华迪光大股权 投资基金（有限合伙）（以下简称"华迪光大"）、广东千灯华迪股权投资企业（有 限合伙）（以下简称"千灯华迪"）、广州盛隆投资合伙企业（有限合伙）（以下简 称"广州盛隆"）、广州六脉资江股权投资合伙企业（有限合伙）（以下简称"六 脉资江"）、贵州沛硕股权投资合伙企业（有限合伙）（以下简称"贵州沛硕"）、 广州资江凯源股权投资合伙企业（有限合伙）（以下简称"资江凯源"）和贵州享 硕股权投资合伙企业（有限合伙）（以下简称"贵州享硕"）具有一致行动关系， 为公司合计持股 5%以上股东。 公司于 2025 年 2 月 14 日披露了《关于合计持股 5%以上股东及其一致行动 人减持股份预披露公告》（公告编号：2025-006）。公司合计持股 5%以上股东及 其一致行动人华迪光大、千灯华迪、六脉资江和资江凯源计划自上述公告披露之 日起 15 个交易日后的 3 个月内（即 2025 年 3 月 10 日至 2025 年 6 月 9 日）通过 集中竞价或大宗交易的方式减持公司股份 4,201,7 ...

Summary of Key Points Core Viewpoint - Shenzhen Longkun Technology Co., Ltd. has approved a guarantee limit for 2025 to support the financing needs of the company and its subsidiaries, with a total guarantee amount not exceeding RMB 1,592.45 million [2]. Group 1: Guarantee Matters - The company has applied for a performance guarantee of RMB 800,000 for its subsidiary, Raoping Longkun Agricultural Resource Technology Co., Ltd. from Huaxia Bank [3]. - The guarantee is aimed at supporting the business operations of the subsidiary, which has a high asset-liability ratio exceeding 70% [2][3]. Group 2: Financial Data of the Subsidiary - As of March 31, 2025, Raoping Longkun Agricultural Resource Technology Co., Ltd. reported total assets of RMB 344.76 million and total liabilities of RMB 247.82 million, resulting in net assets of RMB 96.94 million [4]. - The subsidiary's revenue for the first quarter of 2025 was RMB 8.12 million, with a net loss of RMB 734,500 [4]. Group 3: Overall Guarantee Situation - As of the announcement date, the total guarantee amount for the company and its subsidiaries is RMB 4,141.94 million, with a total guarantee balance of RMB 1,837.95 million, which accounts for a significant portion of the company's audited net assets [5].